Donor lung pathological abnormalities and recipient outcomes
D. Piloni (New York, United States of America), J. Costa (New York, United States of America), A. Urso (New York, United States of America), A. Gomez (New York, United States of America), L. Shah (New York, United States of America), H. Robbins (New York, United States of America), L. Benvenuto (New York, United States of America), J. Sonett (New York, United States of America), S. Arcasoy (New York, United States of America), F. D'Ovidio (New York, United States of America)
Source: International Congress 2018 – Moving lung transplantation forward
Session: Moving lung transplantation forward
Session type: Thematic Poster
Number: 2592
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Piloni (New York, United States of America), J. Costa (New York, United States of America), A. Urso (New York, United States of America), A. Gomez (New York, United States of America), L. Shah (New York, United States of America), H. Robbins (New York, United States of America), L. Benvenuto (New York, United States of America), J. Sonett (New York, United States of America), S. Arcasoy (New York, United States of America), F. D'Ovidio (New York, United States of America). Donor lung pathological abnormalities and recipient outcomes. 2592
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: